ALK and lymphoma: Interestingly, recent preclinical studies indicate that ALK fulfills the major requirements for an ideal OA for lymphoma vaccination [210] and that a vaccine against ALK can induce a strong specific immune response able to impair the growth of ALK-rearranged lung tumors [211].